Silencing circATXN1 in Aging Nucleus Pulposus Cell Alleviates Intervertebral Disc Degeneration via Correcting Progerin Mislocalization
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 7, 0336
Abstract
Circular RNAs (circRNAs) play a critical regulatory role in degenerative diseases; however, their functions and therapeutic applications in intervertebral disc degeneration (IVDD) have not been explored. Here, we identified that a novel circATXN1 highly accumulates in aging nucleus pulposus cells (NPCs) accountable for IVDD. CircATXN1 accelerates cellular senescence, disrupts extracellular matrix organization, and inhibits mitochondrial respiration. Mechanistically, circATXN1, regulated by heterogeneous nuclear ribonucleoprotein A2B1-mediated splicing circularization, promotes progerin translocation from the cell nucleus to the cytoplasm and inhibits the expression of insulin-like growth factor 1 receptor (IGF-1R). To demonstrate the therapeutic potential of circATXN1, siRNA targeting the backsplice junction of circATNX1 was screened and delivered by tetrahedral framework nucleic acids (tFNAs) due to their unique compositional and tetrahedral structural features. Our siRNA delivery system demonstrates superior abilities to transfect aging cells, clear intracellular ROS, and enhanced biological safety. Using siRNA–tFNAs to silence circATXN1, aging NPCs exhibit reduced mislocalization of progerin in the cytoplasm and up-regulation of IGF-1R, thereby demonstrating a rejuvenated cellular phenotype and improved mitochondrial function. In vivo, administering an aging cell-adapted siRNA nucleic acid framework delivery system to progerin pathologically expressed premature aging mice (zmpste24 −/− ) can ameliorate the cellular matrix in the nucleus pulposus tissue, effectively delaying IVDD. This study not only identified circATXN1 functioning as a cell senescence promoter in IVDD for the first time, but also successfully demonstrated its therapeutic potential via a tFNA-based siRNA delivery strategy.Keywords
Funding Information
- National Natural Science Foundation of China (82372486)
- National Natural Science Foundation of China (82072481)
- National Natural Science Foundation of China (82072465)
- National Natural Science Foundation of China (82272480)
- National Natural Science Foundation of China (21975217)
- Science Fund for Distinguished Young Scholars of Zhejiang Province (LR23H060001)
This publication has 58 references indexed in Scilit:
- Bio-inspired, bioengineered and biomimetic drug delivery carriersNature Reviews Drug Discovery, 2011
- DNA Cage Delivery to Mammalian CellsACS Nano, 2011
- Toxicity of cationic lipids and cationic polymers in gene deliveryJournal of Controlled Release, 2006
- Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndromeProceedings of the National Academy of Sciences, 2005
- Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activationNature, 2005
- Oxygen sensitivity severely limits the replicative lifespan of murine fibroblastsNature Cell Biology, 2003
- Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase–deficient miceNature Genetics, 2002
- BAX-dependent transport of cytochrome c reconstituted in pure liposomesNature Cell Biology, 2000
- Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungsGene Therapy, 1999
- Cloning and Developmental Expression Analysis of the Murine Homolog of the Spinocerebellar Ataxia Type 1 Gene (Sea1)Human Molecular Genetics, 1996